SCA
IART icon

SAC Capital Advisors’s Integra LifeSciences IART Stock Holding History

SAC Capital Advisors’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-112,782
Closed -$2.12M – 477
2014
Q1 		$2.12M Buy
+112,782
New +$2.18M 0.01% 744

Other funds holding IART

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

SAC Capital Advisors's IART Position: Q2 2014 in Review

SAC Capital Advisors sold out of Integra LifeSciences (IART) in Q2 2014, closing a stake of 112,782 shares — an estimated $2.12M sold.

SAC Capital Advisors first reported a position in IART in Q1 2014 and held it in 1 quarter. The position peaked at $2.12M in Q1 2014. 147 funds tracked by Wall St. Rank hold IART as of Q2 2014.

  • SAC Capital Advisors reported no remaining Integra LifeSciences position as of Q2 2014 after selling out during the quarter.
  • SAC Capital Advisors sold 112,782 Integra LifeSciences shares in Q2 2014, an estimated $2.12M.
  • SAC Capital Advisors first reported a position in Integra LifeSciences in Q1 2014 and held it in 1 quarter.
  • SAC Capital Advisors's Integra LifeSciences position peaked at $2.12M in Q1 2014.
  • 147 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2014.

Based on SAC Capital Advisors's 13F filing for Q2 2014.